Biting the Magic Bullet: A Look at the SSRI Litigation
August 1, 2002
photo-3icPendicsychotherapeutic drugs are the number one class of drugs in the United States with sales of over $23 billion in 2001 (considerably higher than drugs used to treat cardiovascular disease, cancer, and diabetes).1 Selective Serotonin Reuptake Inhibitors ('SSRIs' -- Prozac, Zoloft, and Paxil in particular), constitute a large, if not the majority, proportion of the psychotherapeutic class of drugs making it the number one therapeutic class. (Id. 56-57.)
The extraordinary increase in the psychotherapeutic drug market appears to have begun with the advent of the SSRIs, the first of which was Eli Lilly Co.'s Prozac. Coincidentally, since …
UPCOMING CONFERENCES
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 25, 2025 - Buffalo, NY
The Westin Buffalo
HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper
May 06, 2025